Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Summary

This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on end of treatment virologic response, sustained virologic response, reduction of quantitative serum HCV RNA, changes in ALT and safety parameters.

Timeline

Start

2005-02

Primary completion

—

Completion

—

Drugs

Indications